Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

TWST

Twist Bioscience Corp

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1581280Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$377.0M
Net Income FY2025
$(78.0M)
EPS (Basic, as reported)
$-1.30
Net Margin FY2025
-20.6%
ROE FY2025
-16.4%
Total Equity
$473.0M
Shares Out
63M
Business description

Twist Bioscience Corp — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2017–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 11 → 377 +55.5% CAGR
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue11255490132204245313377
Cost of revenue(24)(32)(47)(61)(81)(119)(155)(180)(186)
Research & development(19)(20)(36)(43)(69)(120)(107)(91)(80)
Selling, general & administrative(26)(43)(80)(103)(136)(213)(190)(218)(247)
Total operating expenses(69)(96)(163)(230)(285)(438)(462)(534)(513)
Operating income(58)(71)(109)(140)(153)(235)(217)(221)(136)
Interest expense(1)(1)(1)(1)0000—
Interest & investment income013103141511
Other income (expense), net0000(1)(1)(1)(3)(1)
Pre-tax income(59)(71)(107)(140)(154)(228)(203)(208)(77)
Income tax expense0000(2)(10)(1)(1)(1)
Net income(59)(71)(108)(140)(152)(218)(205)(209)(78)
EPS — basic———($3.57)($3.15)($4.04)($3.60)($3.60)($1.30)
EPS — diluted———($3.57)($3.15)($4.04)($3.60)($3.60)($1.30)
Shares outstanding — basic (M)———394854575860
Shares outstanding — diluted (M)———394854575860

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.